Cookson Peirce & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Cookson Peirce & Co’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,034	Closed	-$214K	–	297
2025 Q1	$214K	Buy	+3,034	New	+$211K	0.01%	258
2023 Q2	–	Sell	-4,431	Closed	-$259K	–	239
2023 Q1	$259K	Buy	4,431 +48	+1%	+$2.89K	0.02%	185
2022 Q4	$272K	Hold	4,383	–	–	0.02%	168
2022 Q3	$248K	Sell	4,383 -1,395	-24%	-$85.9K	0.02%	162
2022 Q2	$369K	Buy	+5,778	New	+$367K	0.03%	147
2016 Q1	–	Sell	-26,472	Closed	-$1.43M	–	137
2015 Q4	$1.43M	Sell	26,472 -330	-1%	-$17.4K	0.22%	67
2015 Q3	$1.32M	Sell	26,802 -2,142	-7%	-$123K	0.22%	73
2015 Q2	$1.69M	Buy	28,944 +780	+3%	+$45.6K	0.28%	61
2015 Q1	$1.62M	Sell	28,164 -4,455	-14%	-$244K	0.28%	61
2014 Q4	$1.65M	Sell	32,619 -2,340	-7%	-$114K	0.34%	59
2014 Q3	$1.64M	Sell	34,959 -423	-1%	-$19.1K	0.38%	58
2014 Q2	$1.59M	Buy	35,382 +1,920	+6%	+$82.6K	0.38%	61
2014 Q1	$1.41M	Buy	33,462 +360	+1%	+$15.1K	0.35%	67
2013 Q4	$1.3M	Buy	+33,102	New	+$1.24M	0.35%	68

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cookson Peirce & Co's IHE Position: Q2 2025 in Review

Cookson Peirce & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2025, closing a stake of 3,034 shares — an estimated $214K sold.

Cookson Peirce & Co first reported a position in IHE in Q4 2013 and held it in 14 quarters. The position peaked at $1.69M in Q2 2015. 139 funds tracked by Wall St. Rank hold IHE as of Q2 2025.

Cookson Peirce & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
Cookson Peirce & Co sold 3,034 iShares US Pharmaceuticals ETF shares in Q2 2025, an estimated $214K.
Cookson Peirce & Co first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 14 quarters.
Cookson Peirce & Co's iShares US Pharmaceuticals ETF position peaked at $1.69M in Q2 2015.
139 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2025.

Based on Cookson Peirce & Co's 13F filing for Q2 2025, filed 30 Jul 2025.